There have been 50 recent insider transactions recorded for Travere Therapeutics, Inc. (TVTX), including 12 buys and 36 sells. Total insider buying was valued at $24.03M and total insider selling at $11.49M.
Notable insiders with recent activity include Reed Elizabeth E, Dube Eric M, Inrig Jula. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — TVTX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-01 |
Reed Elizabeth E |
Chief Legal Officer and Gc |
Option Exercise (Sell) |
10,000 |
$15.46 |
$154.6K |
45,000 |
| 2026-04-01 |
Dube Eric M |
Chief Executive Officer |
Option Exercise (Sell) |
60,000 |
$15.46 |
$927.6K |
- |
| 2026-03-16 |
Reed Elizabeth E |
Chief Legal Officer and Gc |
Option Exercise (Sell) |
10,000 |
$19.08 |
$190.8K |
10,000 |
| 2026-02-20 |
Dube Eric M |
Chief Executive Officer |
Option Exercise (Sell) |
60,000 |
$15.46 |
$927.6K |
60,000 |
| 2026-02-17 |
Reed Elizabeth E |
Chief Legal Officer and Gc |
Option Exercise (Sell) |
10,000 |
$19.08 |
$190.8K |
20,000 |
| 2026-02-04 |
Reed Elizabeth E |
Chief Legal Officer and Gc |
Informative Sell |
509 |
$32.74 |
$16.66K |
105,211 |
| 2026-02-04 |
Inrig Jula |
Chief Medical Officer |
Informative Sell |
232 |
$32.85 |
$7.62K |
105,706 |
| 2026-02-04 |
Cline Christopher R. |
Chief Financial Officer |
Informative Sell |
110 |
$32.90 |
$3.62K |
111,226 |
| 2026-02-03 |
Reed Elizabeth E |
Chief Legal Officer and Gc |
Informative Sell |
7,175 |
$32.12 |
$230.46K |
108,205 |
| 2026-02-03 |
Rote William E. |
Chief Research Officer |
Informative Sell |
12,446 |
$32.87 |
$409.1K |
109,087 |
| 2026-02-03 |
Dube Eric M |
Chief Executive Officer |
Informative Sell |
33,635 |
$32.70 |
$1.1M |
432,886 |
| 2026-02-03 |
Heerma Peter |
Chief Commercial Officer |
Informative Sell |
7,310 |
$32.12 |
$234.8K |
131,823 |
| 2026-02-03 |
Calvin Sandra |
SVP, Chief Accounting Officer |
Informative Sell |
4,333 |
$32.12 |
$139.18K |
49,080 |
| 2026-02-03 |
Inrig Jula |
Chief Medical Officer |
Informative Sell |
6,956 |
$32.12 |
$223.43K |
107,485 |
| 2026-02-03 |
Cline Christopher R. |
Chief Financial Officer |
Informative Sell |
7,242 |
$32.12 |
$232.61K |
112,971 |
| 2026-01-31 |
Reed Elizabeth E |
Chief Legal Officer and Gc |
RSU Award |
66,960 |
$33.10 |
$2.22M |
66,960 |
| 2026-01-31 |
Rote William E. |
Chief Research Officer |
RSU Award |
53,570 |
$33.10 |
$1.77M |
53,570 |
| 2026-01-31 |
Dube Eric M |
Chief Executive Officer |
RSU Award |
303,600 |
$33.10 |
$10.05M |
303,600 |
| 2026-01-31 |
Heerma Peter |
Chief Commercial Officer |
RSU Award |
69,640 |
$33.10 |
$2.3M |
69,640 |
| 2026-01-31 |
Calvin Sandra |
SVP, Chief Accounting Officer |
RSU Award |
20,160 |
$33.10 |
$667.2K |
20,160 |
| 2026-01-31 |
Inrig Jula |
Chief Medical Officer |
RSU Award |
75,000 |
$33.10 |
$2.48M |
75,000 |
| 2026-01-31 |
Cline Christopher R. |
Chief Financial Officer |
RSU Award |
75,000 |
$33.10 |
$2.48M |
75,000 |
| 2026-01-27 |
Dube Eric M |
Chief Executive Officer |
Option Exercise (Sell) |
51,865 |
$15.46 |
$801.83K |
120,000 |
| 2026-01-23 |
Dube Eric M |
Chief Executive Officer |
Option Exercise (Sell) |
8,135 |
$15.46 |
$125.77K |
171,865 |
| 2026-01-20 |
Reed Elizabeth E |
Chief Legal Officer and Gc |
Option Exercise (Sell) |
10,000 |
$19.08 |
$190.8K |
30,000 |
| 2026-01-06 |
Inrig Jula |
Chief Medical Officer |
Informative Sell |
445 |
$37.75 |
$16.8K |
86,311 |
| 2026-01-05 |
Inrig Jula |
Chief Medical Officer |
Informative Sell |
2,031 |
$40.18 |
$81.61K |
86,756 |
| 2025-12-24 |
Rote William E. |
Chief Research Officer |
Option Exercise (Sell) |
60,000 |
$20.61 |
$1.24M |
- |
| 2025-12-24 |
Heerma Peter |
Chief Commercial Officer |
Informative Sell |
4,980 |
$40.00 |
$199.2K |
113,013 |
| 2025-12-24 |
Calvin Sandra |
SVP, Chief Accounting Officer |
Informative Sell |
7,402 |
$40.00 |
$296.08K |
38,233 |
| 2025-12-24 |
Inrig Jula |
Chief Medical Officer |
Option Exercise (Sell) |
15,000 |
$8.93 |
$133.95K |
76,000 |
| 2025-12-15 |
Calvin Sandra |
SVP, Chief Accounting Officer |
Informative Sell |
2,910 |
$36.00 |
$104.76K |
45,635 |
| 2025-12-01 |
Cline Christopher R. |
Chief Financial Officer |
Option Exercise (Sell) |
20,000 |
$16.23 |
$324.6K |
- |
| 2025-11-04 |
Calvin Sandra |
SVP, Chief Accounting Officer |
Option Exercise (Sell) |
17,500 |
$26.88 |
$470.4K |
- |
| 2025-11-03 |
Heerma Peter |
Chief Commercial Officer |
Gift (Given) |
1,078 |
- |
- |
117,993 |
| 2025-10-31 |
Coughlin Timothy |
Director |
Option Exercise (Sell) |
10,000 |
$17.44 |
$174.4K |
- |
| 2025-10-31 |
Heerma Peter |
Chief Commercial Officer |
Informative Sell |
5,591 |
$35.00 |
$195.69K |
119,071 |
| 2025-10-29 |
Dube Eric M |
Chief Executive Officer |
Option Exercise (Sell) |
27,128 |
$15.46 |
$419.4K |
180,000 |
| 2025-10-28 |
Dube Eric M |
Chief Executive Officer |
Option Exercise (Sell) |
92,872 |
$15.46 |
$1.44M |
207,128 |
| 2025-10-28 |
Heerma Peter |
Chief Commercial Officer |
Informative Sell |
2,662 |
$30.00 |
$79.86K |
124,662 |
| 2025-09-23 |
Heerma Peter |
Chief Commercial Officer |
Gift (Given) |
891 |
- |
- |
127,324 |
| 2025-09-22 |
Reed Elizabeth E |
Chief Legal Officer and Gc |
Option Exercise (Sell) |
10,000 |
$19.08 |
$190.8K |
40,000 |
| 2025-09-04 |
Cline Christopher R. |
Chief Financial Officer |
Informative Sell |
119 |
$19.71 |
$2.35K |
92,083 |
| 2025-09-03 |
Cline Christopher R. |
Chief Financial Officer |
Informative Sell |
454 |
$18.20 |
$8.26K |
92,202 |
| 2025-08-27 |
Cline Christopher R. |
Chief Financial Officer |
Informative Sell |
470 |
$17.31 |
$8.14K |
92,656 |
| 2025-05-15 |
Lyons Gary A |
Director |
RSU Award |
19,500 |
$21.15 |
$412.43K |
19,500 |
| 2025-05-15 |
Williams Brinkley Ruth |
Director |
RSU Award |
19,500 |
$21.15 |
$412.43K |
19,500 |
| 2025-05-15 |
Coughlin Timothy |
Director |
RSU Award |
19,500 |
$21.15 |
$412.43K |
19,500 |
| 2025-05-15 |
Squarer Ron |
Director |
RSU Award |
19,500 |
$21.15 |
$412.43K |
19,500 |
| 2025-05-15 |
Orwin John A |
Director |
RSU Award |
19,500 |
$21.15 |
$412.43K |
19,500 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
